Cannabidiol, neuroprotection and neuropsychiatric disorders.
Neurological Aspects of Medical Use of Cannabidiol.
Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival.
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.
The endocannabinoid system in targeting inflammatory neurodegenerative diseases.